Browsing by Author "Kofron, Ryan"
Now showing items 1-7 of 7
-
Cabotegravir is not associated with weight gain in HIV-uninfected individuals in HPTN 077
Landovitz, Raphael J. et al. | Date Issued: 2019 -
Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus–uninfected Individuals in HPTN 077
Landovitz, Raphael J. et al. | Date Issued: 2020 -
Characterization of Human Immunodefciency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Marzinke, Mark A. et al. | Date Issued: 2021 -
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Marzinke, Mark A. et al. | Date Issued: 2023 -
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention
Eshleman, Susan H. et al. | Date Issued: 2022 -
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
Landovitz, Raphael J et al. | Date Issued: 2018 -
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
Landovitz, Raphael J. et al. | Date Issued: 2020